4 edition of Prevalence and continuation of injectable contraceptives found in the catalog.
Prevalence and continuation of injectable contraceptives
Rahman, Md. Mafizur.
by Centre for Health and Population Research, International Centre for Diarrhoeal Disease Research in Dhaka
Written in English
|Statement||Md. Mafizur Rahman ... [et al.].|
|Series||ICDDR,B working paper ;, no. 53, Working paper ;, no. 116, Working paper (International Centre for Diarrhoeal Disease Research, Bangladesh) ;, no. 53., Working paper (MCH-FP Extension Project (Rural) (Bangladesh)) ;, no. 116.|
|Contributions||International Centre for Diarrhoeal Disease Research, Bangladesh., MCH-FP Extension Project (Rural) (Bangladesh)|
|The Physical Object|
|Pagination||v, 11 p. ;|
|Number of Pages||11|
|LC Control Number||2005323916|
Initiation and Continuation of Injectable Contraceptives by Community Health Workers Description: Summarizes the evidence on community health worker (CHW) provision of injectable contraceptives in sub-Saharan Africa that validates the feasibility and safety of CHW initiation and continuation of injectable contraceptives. Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey. Khalifa AM, Sayed HA, El-khorazaty MN, Way AA. Egypt Popul Fam Plann Rev, 16(2), 01 Dec Cited by: 0 articles | PMID:
means of improving method continuation. In this study, we developed and evaluated a communi-cation campaign to increase contraceptive continuation rates among first-time injectable users in Nyando District, Kenya. Theoretical Model Our model for predicting contraceptive continuation expands on the Bruce-Jain framework22 and has been. Users who are well informed regarding their method's side effects have the highest contraceptive satisfaction and continuation rates. 10,11,12,13 Hence, before initiation of DMPA contraception, clinicians should ensure that candidates recognize this method's most common side effects. As with all long-acting progestin contraceptives, menstrual.
CONCLUSIONS: Acceptor prevalence and continuation rate of progestogen-only injectable contraceptive are low. There is need for more enlightenment campaigns to . increase the contraceptive prevalence rate. In Kenya for example, adding community-based provision of injectable contraceptives to the method mix dramatically increased contraceptive uptake and improved method choice during their pilot program. 2. Because community-based access to injectable contraceptives (CBA2I) has the potential to.
Peru, a bibliography of books in English.
A pictorial history of Black soldiers in the United States (1619-1969)
James Short and his telescopes.
Scottish property portfolio and review.
Observations on the history and treatment of the opthalmia accompanying the secondary forms of lues venerea ...
Proceedings of the Conference of Federal and Provincial Governments Ottawa, December 4-7, 1950.
education of an army
Inter-American efforts to relieve international tensions in the Western Hemisphere, 1959-1960.
Illinois plan for special education of exceptional children
Progestogen-only injectable contraceptives (POICs) are slow-release preparations lasting 2 or 3 months. Depot medroxyprogesterone acetate (DMPA) and norethisterone enantate (NET-EN) are the two POICs available in the UK.
DMPA is licensed as a first-line contraceptive for. According to a multicountry analysis, the median duration of injectable contraceptive use is months — lower than for IUDs, condoms, pills and traditional methods — and the probability of continuation of injectable contraception at 12 months is %.
Relative to this finding, women in the Burkina Faso study who received either DMPA product from clinic-based health workers had low injectable continuation rates Cited by: 3. While injectable contraceptives are popular throughout much of sub-Saharan Africa, they have high rates of discontinuation.
This study is the second from an African country to demonstrate that self-injection may improve injectable continuation rates and may do so without increasing the risk of pregnancy or adverse by: A total of clients used the injectable progestogen-only contraceptive out of total contraceptive users giving the prevalence rate of % over the period.
Of these, % of the clients accepted the depot medroxyprogesterone acetate, while % accepted the norethisterone : Charles O.
Njoku, Cajethan I. Emechebe, Christopher U. Iklaki, Amarachukwu N. Njoku, Jenkins T. Ukag. Long-acting reversible contraception users had higher month continuation rates (86%) than OCP users (55%).
The two IUDs had the highest month continuation rates: levonorgestrel intrauterine system (88%) and copper IUD (84%). Women using the implant also had very high rates of Cited by: How acceptable are injectable contraceptives: Experiences of users and health care providers in India.
Given the low prevalence of injectable contraceptive use in India, a community-based study was not continuation of injectable contraceptive use among. A growing number of contraceptive users rely on injectable contraceptives for preventing unintended pregnancy.
Injectable use doubled between and and is estimated to provide protection for more than 42 million women worldwide every year , .Cited by: The month continuation rate for the women self-injecting DMPA-SC was [95% confidence interval (CI)–], and for women receiving DMPA-IM from a health worker, it was (95% CI–), a significant difference at the level.
There were no differences in pregnancy rates Cited by: The contraceptive prevalence of injectable contraceptives is per cent worldwide (Department of Economic and Social Affairs, ). Currently, an estimated 42 million women worldwide use injectables as a method of choice.
This is a significant increase over the years from 12 million in File Size: KB. CICs are different from progestogen-only injectable contraceptives (POICs), such as depot medroxyprogesterone acetate (DMPA; brand names Depo-Provera, Depo-SubQ Provera ) and norethisterone enantate (NETE; brand name Noristerat), which are not combined with an estrogen and are given once every two to three months instead of once a month.
Hormonal contraception works First use: About Management of Common Contraceptive Problems: A Problem Solving Injectable Contraceptives 23 Progestin-Only Injectable Contraceptives 23 4.
SUBDERMAL IMPLANTS 31 5. INTRAUTERINE CONTRACEPTIVE DEVICES (IUD/IUCD) 39 6. VOLUNTARY SURGICAL CONTRACEPTION 47 CPR Contraceptive prevalence rate ECP Emergency contraception pill EE Ethinyl estradiol. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
Cover J(1), Namagembe A(2), Tumusiime J(3), Nsangi D(4), Lim J(5), Nakiganda-Busiku D(6).Cited by: New contraceptive methods that are designed for increased access and ease of use, combined with high quality provision, have potential to increase contraceptive use in settings with low levels of contraceptive prevalence.
Higher quality counseling can help encourage women's continuation of a new injectable contraceptive method at 3 by: 7. Progestogen-only injectable contraceptive is highly effective, long lasting and reversible agent of a fertility control.
The objective is to determine the profile of the acceptors, side effects and indica-tion for discontinuation of progestogen-only injectable contraceptives at UCTH, Calabar.
This was a. Contraceptive prevalence increased between and regardless of the number of living children. Fertility differentials included age, maternal education, and occupational status.
Read more. Zibners, Cromer, and Hayes: Continuation Rates for Hormonal Contraception Among Adolescents son of continuous variables. Kaplan-Meier curves were constructed to display continuation rates.* Results The demographic makeup of the patient population was % ( of ) black, % ( of ) white, and % (8 of ) other, with no Cited by: sell a range of contraceptives including condoms, emergency contraceptive pills, refills of oral contraceptive pills, and intrauterine devices (with a referral).
Injectable contraception is the most popular modern method in Nigeria, used by more than 30 percent of currently married modern contraceptive users. CurrentFile Size: KB. Studies are needed to advance the understanding of non-medical reasons for discontinuation of combination injectable contraceptives.
Trials could be conducted to determine whether providing women with three months' supply of a combined injectable contraceptive improves continuation rates. Background: The contraceptive injectable is a safe and effective method that is used worldwide.
With the variety of injectable delivery systems, there is potential for administration by the woman. Some studies suggest that women using progestogen- only injectable contraception may be at increased risk of HIV acquisition; other studies have not found this association.
The public health impact of any such association would depend upon the local context, including rates of injectable contraceptive use, maternal mortality, and HIV prevalence. 2. Provide women full and accurate information on all contraceptive options, including injectable contraception.
3. Consider the potential for the novel injectable DMPA-SC to: o. Expand access. o. Reach new users of modern family planning. o. Improve continuation, especially through self-injection (the ultimate task-sharing) 5.Continuation of injectable contraception when self-injected v.
administered by a facility-based health worker: A non-randomized, prospective cohort study in Uganda.Sustained method use is particularly problematic among users of the injectable contraceptive.
In Kenya, the injectable is the most popular method—used by 22% of married women in ; however, 29% discontinued use within 12 months of starting.